Posts Tagged ‘Chlamydia’

Rerouting of Host Lipids by Bacteria

Wednesday, September 14th, 2011

Lipid vesicles Fifteen years ago, in a series of elegant studies, Hackstadt and colleagues showed that the obligate intracellular bacteria Chlamydia trachomatis save on their lipid needs by incorporating sphingomyelins (SMs) made by their host. Shortly after, Hatch and McClarty’s teams reported that several eukaryotic glycerophospholipids are also trafficked from the host to the bacteria, which replace host-synthesized straight-chain fatty acids by their own branched-chain fatty acids. Even cholesterol, a lipid rarely found in bacteria, was shown to accumulate in Chlamydia. As a result of this intense exploitation of host lipids, the composition of the bacterial membrane is closer to that of a eukaryotic cell than to that of a prokaryote.

Throughout their developmental cycle, chlamydiae reside within a membrane-bounded compartment, the inclusion. How they acquire host lipids remains an open question. Possible mechanisms studied so far involve vesicular trafficking from host compartments, including vesicular traffic out of the Golgi apparatus, fusion with multivesicular body–derived vesicles, and engulfment of lipid droplets.

 

Rerouting of Host Lipids by Bacteria: Are You CERTain You Need a Vesicle? (2011) PLoS Pathog 7(9): e1002208. doi:10.1371/journal.ppat.1002208

Students pee in a pot

Friday, November 19th, 2010

Urine sample Chlamydia is the most prevalent bacterial sexually transmitted infection (STI) in the western world. In Ireland, the number of chlamydia notifications increased from 245 in 1995 to 6290 in 2008. While this may reflect a real rise in the burden of chlamydia infection, it also reflects an increase in provider awareness in chlamydia testing, test performance and the introduction of laboratory notification. The real burden (numbers of infection) is likely to be higher than reported as chlamydia is asymptomatic in approximately 70% of women and 50% of men and thus may remain undiagnosed. Prevalence studies in young Irish people (including students) have shown similar rates of infection to the UK and else where in Europe.

In view of the asymptomatic nature of chlamydia, especially in women, there is recognition that it is important to screen sexually active women aged less than 25 years. Two approaches are proposed: systematic, where all eligible young persons are systematically invited for screening, which requires the availability of a unique identifier for each individual to ensure all eligible persons are invited and not invited again except where indicated; and opportunistic, where eligible young persons that are visiting/utilising clinical and non-clinical settings are invited to take a test.

These issues highlight the need for additional strategies for screening that are free at the point of testing, easy to access, private and available in a variety of settings. Screening strategies need to be ‘youth friendly’ and available outside of traditional medical facilities.

Pee-in-a-Pot: acceptability and uptake of on-site chlamydia screening in a student population in the Republic of Ireland. (2010) BMC Infectious Diseases 10: 325 doi:10.1186/1471-2334-10-325
Background: The aim of the study was to explore the acceptability and uptake of on-campus screening using a youth friendly approach in two Third Level higher education institutions (HEIs). This study is part of wider research exploring the optimal setting for chlamydia screening in Ireland.
Methods: Male and female students were given the opportunity to take a free anonymous test for chlamydia during a one week programme of “pee-in-a-pot” days at two HEI campuses in the West of Ireland. The study was set up after extensive consultation with the two HEIs and advertised on the two campuses using a variety of media in the two weeks preceding the screening days. Screening involved the provision and distribution of testing packs at communal areas and in toilet facilities. In Ireland, chlamydia notifications are highest amongst 20-29 year olds and hence the screening criterion was aimed at 18-29 year olds. Urine samples were tested using a nucleic acid amplification test (NAAT). Following the screening days, qualitative in-depth interviews were conducted with participants about their experiences of the event.
Results: Out of 1,249 test kits distributed in two HEIs, 592 specimens were collected giving a return rate of 47.5%. Tests excluded (54) were due to labelling errors or ineligibility of participants’ age. Two thirds of those tested were females and the mean age was 21 years. Overall, 3.9% (21/538) of participants tested positive, 5% (17/336) among females and 2% (4/191) among males. Participant interviews identified factors which enhanced student participation such as anonymity, convenience, accessibility of testing, and the informal and non-medical approach to testing.
Conclusions: Screening for chlamydia using on-campus “pee-in-a-pot” days is an acceptable strategy in this population. This model can detect and treat asymptomatic cases of chlamydia and avoid many of the barriers associated with testing for sexually transmitted infections (STIs) in clinical settings.

Related:

New insights into the evolution of Chlamydia pneumoniae

Tuesday, June 1st, 2010

Chlamydia pneumoniae Chlamydia pneumoniae is an intracellular bacterial pathogen with an extremely diverse host range (humans, amphibians, reptiles and marsupials). C. pneumoniae exposure is widespread in humans, with sero-prevalence studies reporting 50% infection levels by age 20 and reaching 80% in the elderly. In humans, C. pneumoniae infections can range from asymptomatic to severe respiratory disease, including pneumonia. Less common presentations include bronchitis, pharyngitis, laryngitis and sinusitis, making up 5% of cases. In addition to respiratory infections in humans, C. pneumoniae has also been associated with atherosclerosis and stroke, myocarditis, multiple sclerosis and Alzheimer’s disease.

Despite the widespread prevalence of C. pneumoniae in humans, all isolates studied to date are extremely similar at the DNA level. Four C. pneumoniae human isolates have had their full genome sequenced. Genomic comparisons revealed a highly conserved (>99.9%) gene order and organisation, with few deletions and less than 300 single nucleotide polymorphisms (SNPs) distinguishing the isolates. This near clonality of C. pneumoniae human isolates that are temporally and geographically separate, has been taken to indicate that human infections are a relatively recent event and that the efficient respiratory spread of the agent explains how 60–80% of adults worldwide have been infected at least once in their lifetime .

Researchers selected 23 target genes in this organism to investigate genetic diversity: seven of these had been lost or gained by C. pneumoniae, a further six were conserved, four were polymorphic, and six were truncated or length polymorphic in one strain or the other. The results highlights that C. pneumoniae animal isolates are much more genetically diverse than C. pneumoniae human isolates, and have crossed the host barrier to humans on at least two occasions. This study provides new insights into the evolution of this complex pathogen.

Chlamydia pneumoniae Is Genetically Diverse in Animals and Appears to Have Crossed the Host Barrier to Humans on (At Least) Two Occasions. 2010 PLoS Pathog 6(5): e1000903. doi:10.1371/journal.ppat.1000903

Related:

Telling partners about chlamydia – how ?

Tuesday, April 6th, 2010

Chlamydia Partner notification is accepted as a vital component in the control of chlamydia. However, in reality, many sexual partners of individuals diagnosed with chlamydia are never informed of their risk. The newer technologies of email and SMS have been used as a means of improving partner notification rates. This study explored the use and acceptability of different partner notification methods to help inform the development of strategies and resources to increase the number of partners notified. Semi-structured telephone interviews were conducted with 40 people who were recently diagnosed with chlamydia from three sexual health centres and two general practices across three Australian jurisdictions. Most participants chose to contact their partners either in person (56%) or by phone (44%). Only 17% chose email or SMS. Participants viewed face-to-face as the “gold standard” in partner notification because it demonstrated caring, respect and courage. Telephone contact, while considered insensitive by some, was often valued because it was quick, convenient and less confronting. Email was often seen as less personal while SMS was generally considered the least acceptable method for telling partners. There was also concern that emails and SMS could be misunderstood, not taken seriously or shown to others. Despite these, email and SMS were seen to be appropriate and useful in some circumstances. Letters, both from the patients or from their doctor, were viewed more favourably but were seldom used. These findings suggest that many people diagnosed with chlamydia are reluctant to use the new technologies for partner notification, except in specific circumstances, and our efforts in developing partner notification resources may best be focused on giving patients the skills and confidence for personal interaction.

Telling partners about chlamydia: how acceptable are the new technologies? BMC Infectious Diseases 2010, 10:58 doi:10.1186/1471-2334-10-58

Related:

Chlamydia use proteolysis to evade host defences

Thursday, October 15th, 2009

Chlamydia trachomatis Multiple species of Chlamydia exist, which have a diverse range of tissue tropisms and are involved in various diseases. Chlamydia trachomatis and Chlamydia pneumoniae are human pathogens causing ocular and urogenital tract infections, and respiratory infection, respectively. Despite profound differences in host range, different species of Chlamydia display a remarkable similarity in their genome sequences and possess a conserved intracellular growth cycle with distinct biphasic stages. The infectious particle (also called elementary body or EB) can invade non-phagocytic epithelial cells via induced phagocytosis. The EB-laden cytoplasmic vacuole (also called inclusion) migrates to the peri-Golgi region as the EB starts to differentiate into a noninfectious but metabolically active reticulate body (RB) that can undergo rapid replication. The progeny RBs eventually differentiate back to EBs for spreading to other cells. The entire intracellular growth cycle occurs within the initial inclusion that expands to occupy a large proportion of the host cytoplasmic space as the parasites replicate. It takes several days for most human chlamydiae to complete a productive infection cycle in cell culture. However, infection in humans can become persistent, during which the RBs, instead of undergoing rapid replication and differentiating into infectious EBs, are limited in numbers and each becomes the so-called aberrant or persistent body with enlarged size and multiple nucleoids. The aberrant body-laden inclusions can persist in the infected hosts for long periods of time. Intracellular survival and growth are considered major contributors to chlamydial pathogenesis. Some infected women, if untreated, can develop inflammatory pathologies, including pelvic inflammatory diseases, ectopic pregnancy and infertility.

Killing me softly: chlamydial use of proteolysis for evading host defenses. Trends Microbiol. Sep 16 2009
Chlamydial infections in humans cause severe health problems, including blinding trachoma and sexually transmitted diseases. Although the involved pathogenic mechanisms remain unclear, the ability to replicate and maintain long-term residence in the infected cells seems to significantly contribute to chlamydial pathogenicity. These obligate intracellular parasites maintain a delicate balance between exploiting and protecting their host: they occupy intracellular space and acquire nutrients from the infected cells, but at the same time they have to maintain the integrity of the host cells for the completion of their intracellular growth. For this purpose, chlamydiae hijack certain signaling pathways that prevent the host cells from undergoing apoptosis induced by intracellular stress and protect the infected cells from recognition and attack by host defenses. Interestingly, one of the strategies that chlamydiae use for these purposes is the induction of limited proteolysis of host proteins, which is the main focus of this article.

Related: